Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1838]

PARP inhibitory velaparib trialled in BRCA1/2 breast cancer

Dr Heather Han - H. Lee Moffitt Cancer Center, Tampa, USA

PARP inhibitory velaparib trialled in BRCA1/2 breast cancer ( Dr Heather Han - H. Lee Moffitt Cancer Center, Tampa, USA )

Matched mutations in the progression of metastatic breast cancer

Dr Ofir Cohen - Broad Institute of MIT and Harvard, Cambridge, USA

Matched mutations in the progression of metastatic breast cancer ( Dr Ofir Cohen - Broad Institute of MIT and Harvard, Cambridge, USA )

Positive impact of specialised surgery in the fight against cancer

ESSO - SSO - BSSO

Positive impact of specialised surgery in the fight against cancer ( ESSO - SSO - BSSO )

Infographic: Addressing unmet needs in metastatic breast cancer

Infographic: Addressing unmet needs in metastatic breast cancer ( )

The need to better understand pathways that drive ER＋ metastatic breast cancer

Dr Julie Gralow - University of Washington, Washington, USA

The need to better understand pathways that drive ER＋ metastatic breast cancer ( Dr Julie Gralow - University of Washington, Washington, USA )

The experience of NGOs in Mexican cancer control

Berthar Aguilar - Fundación Cimab, Mexico City, Mexico

The experience of NGOs in Mexican cancer control ( Berthar Aguilar - Fundación Cimab, Mexico City, Mexico )

Breast cancer screening in the Philippines

Kara Alikpala - ICanServe Foundation, Manila, Philippines

Breast cancer screening in the Philippines ( Kara Alikpala - ICanServe Foundation, Manila, Philippines )

Expert discussion on CDK 4/6 inhibition in breast cancer

Prof Richard Finn, Prof Michael Gnant, Dr Mark Harries and Prof Sandra Swain

Expert discussion on CDK 4/6 inhibition in breast cancer ( Prof Richard Finn, Prof Michael Gnant, Dr Mark Harries and Prof Sandra Swain )

PD-1 therapy with eribulin for triple negative MBC

Dr Sara Tolaney - Dana–Farber Cancer Institute, Boston, USA

PD-1 therapy with eribulin for triple negative MBC ( Dr Sara Tolaney - Dana–Farber Cancer Institute, Boston, USA )

Women experiencing menopause symptoms less likely to adhere to medication

Dr Samuel Smith - University of Leeds, Leeds, UK

Women experiencing menopause symptoms less likely to adhere to medication ( Dr Samuel Smith - University of Leeds, Leeds, UK )

Breast cancer mortality declining globally

Dr Cécile Pizot - International Prevention Research Institute, Lyon, France

Breast cancer mortality declining globally ( Dr Cécile Pizot - International Prevention Research Institute, Lyon, France )

Everolimus extends PFS for HR positive, HER2 negative breast cancer

Dr Noah Kornblum - Montefiore Medical Center, New York, USA

Everolimus extends PFS for HR positive, HER2 negative breast cancer ( Dr Noah Kornblum - Montefiore Medical Center, New York, USA )

More from ecancer